Nestor SM

Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

8 papers · ORCID

ArticleKetamine

Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey.

Syed OA, Petranker R, Nestor SM +6

Europe PMC2026
ArticleKetamine

Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.

Syed OA, Sobolenko V, Nestor SM +4

Europe PMC2026
ArticlePsilocybin

Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis.

Syed OA, Tsang B, Nestor SM +4

Europe PMC2026
ArticleMDMA

Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).

Syed OA, Nestor SM, Husain MI +3

Europe PMC2026
ArticleKetamine

Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.

Gutierrez G, Vazquez G, Ravindran N +8

Europe PMC2025
ArticleKetamine

Genetics of Response to ECT, TMS, Ketamine and Esketamine.

Franklin CE, Altinay M, Bailey K +17

Europe PMC2025
ArticleKetamine

IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression.

Gutierrez G, Swainson J, Ravindran N +10

Europe PMC2024
ArticlePsilocybin

Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.

Poulin JM, Bigford GE, Lanctôt KL +13

Europe PMC2024